Skip to content

World Mosquito Program Noumea - Human Sample Component

World Mosquito Program Noumea - Human Sample Component

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03552094
Enrollment
500
Registered
2018-06-11
Start date
2018-06-25
Completion date
2023-06-30
Last updated
2022-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arbovirus Infections

Keywords

Arbovirus

Brief summary

The dengue, Zika and chikungunya arboviruses represent potentially severe infections to which the New Caledonian population is exposed. In the absence of specific treatment or vaccine, vector control remains the method of choice to limit their spread. However, the traditional methods of prevention and vector control measure today face their limits: mosquito resistance to insecticides, difficulty of access and destruction of breeding areas... The World Mosquito Program Noumea project is based on the artificial colonization of the mosquito vector Aedes aegypti by the endosymbiotic bacteria Wolbachia, which reduces its ability to transmit arboviruses. The breeding of mosquitoes carrying the bacterium Wolbachia in the laboratories of the Institut Pasteur of New Caledonia requires the use of human blood samples for mosquito gorging. The objective of the research is to generate, maintain and amplify Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria for the planned insect release program in Noumea.

Detailed description

The dengue, Zika and chikungunya arboviruses represent potentially severe infections to which the New Caledonian population is exposed. In the absence of specific treatment or vaccine, disease vector control remains the method of choice to limit their spread. However, the traditional methods of prevention and disease vector control must today face their limits: mosquito resistance to insecticides, difficulty of access and destruction of breeding areas... The World Mosquito Program Noumea project is based on the artificial colonization of the mosquito vector Aedes aegypti by the endosymbiotic bacterium Wolbachia, which reduces its ability to transmit arboviruses. The breeding of mosquitoes carrying the bacterium Wolbachia in the laboratories of the Institut Pasteur of New Caledonia requires the use of human blood samples for mosquito gorging. The objective of the research is to generate, maintain and amplify Aedes aegypti Caledonian lineages carrying the bacterium Wolbachia for the planned insect release program in Noumea. The establishment of Wolbachia in Aedes aegypti populations in Noumea should lead to the reduction of active transmission of dengue, Zika and chikungunya in the municipality.

Interventions

OTHERBlood donations of hemochromatosis or polycythemia patients

Blood samples are from blood donations of hemochromatosis or polycythemia patients requiring therapeutic bleeding that are not used in medical applications.

OTHERBlood donations of healthy donors

Blood samples are from blood donations of healthy donors.

Sponsors

Institut Pasteur of New Caledonia
CollaboratorUNKNOWN
Institut Pasteur
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All adult hemochromatosis or polycythemia patients or healthy donors have given their written consent to participate in the study and for the collection of a blood sample.

Exclusion criteria

* Participation refusal * Minor person * Positive result by Reverse transcription polymerase chain reaction RT-PCR for arboviruses * Invalid qualification of the blood donation

Design outcomes

Primary

MeasureTime frameDescription
Generation of Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria36 monthsGeneration of Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria for the planned insect release program in Noumea by measuring the Aedes aegypti female gorging rate
Maintenance and amplification of Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria36 monthsMaintenance and amplification of Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria for the planned insect release program in Noumea by measuring the number of eggs per Aedes Aegypti female gorged

Secondary

MeasureTime frameDescription
Vector competence assessment of the different Aedes aegypti Caledonian lineages36 monthsAssessment of the vector competence for the dengue, Zika and chikungunya viruses of the different Aedes aegypti Caledonian lineages with or without Wolbachia bacteria carriage by measuring the transmissibility reduction of Aedes aegypti carrying Wolbachia for arboviruses

Countries

France

Contacts

Primary ContactVincent Richard
vrichard@pasteur.nc+687 27.26.66
Backup ContactNicolas Pocquet
npocquet@pasteur.nc+687 27.26.66

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026